hotspot -WSS

hotspot

author：hotspot 2025-09-08 11:05:19 - browse：75431

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Female surgeons have lower rates of long

WSS

Prime Medicine says its gene editing passes test in monkeys

Medicare to cover more brain scans related to Alzheimer’s drugs

Bill would allow buprenorphine prescription for addiction via telehealth

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Medicare to cover more brain scans related to Alzheimer’s drugs

Cancer cells are shown to suck energy source from immune cells

focus

hotspot

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

The health care issue Democrats can’t solve: hospital reform

Moonlake's readout produced a cash windfall. Risks remain

Gene therapy’s promise and the high cost of hope

The high cost of giving birth even with insurance

Bill would allow buprenorphine prescription for addiction via telehealth

Affirmative action in medical school literally saved lives

Medicare to cover more brain scans related to Alzheimer’s drugs

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

hotspot

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Takeaways from AdvaMed, the largest medical devices conference

Bill would allow buprenorphine prescription for addiction via telehealth

What the Wegovy shortage looks like for doctors — and for patients

Gene therapy’s promise and the high cost of hope

Travis Kelce and the trap of celebrity vaccine endorsements

explore

Wikipedia

hotspot

knowledge